Rob Capone

Telegraph Hill Partners thesis

Meet the Team View All J. Matthew Mackowski Chairman, Managing Director jmm@thpartners.net Matt has been a healthcare-focused venture capital investor since 1980 and began his career as an investment professional with Citicorp Venture Capital.  In 1991 he formed Mackowski & Shepler, the predecessor to Telegraph Hill Partners, and over nine years took an active or founding role with eight companies, primarily in medical and life science technologies.  Matt has represented THP on the boards of Althea Technologies (acquired by Ajinomoto), Ambion (acquired by Applied Biosystems), Asuragen (acquire

Sector and stage focus

• Series B: BioTech, Pharmaceuticals
• general: Raleigh-Durham / Southeast US

Is Rob Capone a fit for your round?

Upload your pitch deck and see whether Rob Capone appears in your top 20 matches.